These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37427415)

  • 21. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
    Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
    Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ribosomal protein L34 promotes the proliferation, invasion and metastasis of pancreatic cancer cells.
    Wei F; Ding L; Wei Z; Zhang Y; Li Y; Qinghua L; Ma Y; Guo L; Lv G; Liu Y
    Oncotarget; 2016 Dec; 7(51):85259-85272. PubMed ID: 27845896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer.
    Ding C; Luo J; Li L; Li S; Yang L; Pan H; Liu Q; Qin H; Chen C; Feng J
    J Exp Clin Cancer Res; 2016 Jan; 35():5. PubMed ID: 26754532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-630 inhibits papillary thyroid carcinoma cell growth, metastasis, and epithelial-mesenchymal transition by suppressing JAK2/STAT3 signaling pathway.
    Pan XM; He XY; Yang YL; Jia WJ; Yang ZQ; Yan D; Ma JX
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2453-2460. PubMed ID: 30964171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of ALK4 inhibits cell proliferation and migration through the inactivation of JAK/STAT3 signaling pathway in glioma.
    Song C; Fan B; Xiao Z
    Biomed Pharmacother; 2018 Feb; 98():440-445. PubMed ID: 29278854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brusatol inhibits laryngeal cancer cell proliferation and metastasis via abrogating JAK2/STAT3 signaling mediated epithelial-mesenchymal transition.
    Zhou J; Hou J; Wang J; Wang J; Gao J; Bai Y
    Life Sci; 2021 Nov; 284():119907. PubMed ID: 34453950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Forkhead Box S1 mediates epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway to regulate colorectal cancer progression.
    Zhang L; Ren CF; Yang Z; Gong LB; Wang C; Feng M; Guan WX
    J Transl Med; 2022 Jul; 20(1):327. PubMed ID: 35864528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opa interacting protein 5 promotes metastasis of nasopharyngeal carcinoma cells by promoting EMT via modulation of JAK2/STAT3 signal.
    Zheng YQ; Cui YR; Yang S; Wang YP; Qiu YJ; Hu WL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):613-621. PubMed ID: 30720169
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Li Y; Wei J; Sun Y; Zhou W; Ma X; Guo J; Zhang H; Jin T
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circular RNA circ_0000372 contributes to the proliferation, migration and invasion of colorectal cancer by elevating IL6 expression via sponging miR-495.
    Liu X; Qin Y; Tang X; Wang Y; Bian C; Zhong J
    Anticancer Drugs; 2021 Mar; 32(3):296-305. PubMed ID: 33534412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. STAM2 knockdown inhibits proliferation, migration, and invasion by affecting the JAK2/STAT3 signaling pathway in gastric cancer.
    Yang Y; Zhang Q; Liang J; Yang M; Wang Z; Tang D; Wang D
    Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):697-706. PubMed ID: 33778841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway.
    Wang Y; Jing Y; Ding L; Zhang X; Song Y; Chen S; Zhao X; Huang X; Pu Y; Wang Z; Ni Y; Hu Q
    J Exp Clin Cancer Res; 2019 Jun; 38(1):274. PubMed ID: 31234944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The autophagy-independent role of BECN1 in colorectal cancer metastasis through regulating STAT3 signaling pathway activation.
    Hu F; Li G; Huang C; Hou Z; Yang X; Luo X; Feng Y; Wang G; Hu J; Cao Z
    Cell Death Dis; 2020 May; 11(5):304. PubMed ID: 32358527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silencing of Ribosomal Protein L34 (RPL34) Inhibits the Proliferation and Invasion of Esophageal Cancer Cells.
    Fan H; Li J; Jia Y; Wu J; Yuan L; Li M; Wei J; Xu B
    Oncol Res; 2017 Aug; 25(7):1061-1068. PubMed ID: 28109079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. cMET promotes metastasis and epithelial-mesenchymal transition in colorectal carcinoma by repressing RKIP.
    Wang S; Ma H; Yan Y; Chen Y; Fu S; Wang J; Wang Y; Chen H; Liu J
    J Cell Physiol; 2021 May; 236(5):3963-3978. PubMed ID: 33151569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
    Yang Z; Wu D; Chen Y; Min Z; Quan Y
    Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of PYCR1 inhibits proliferation, drug resistance and EMT in colorectal cancer cells by regulating STAT3-Mediated p38 MAPK and NF-κB signalling pathway.
    Yan K; Xu X; Wu T; Li J; Cao G; Li Y; Ji Z
    Biochem Biophys Res Commun; 2019 Dec; 520(2):486-491. PubMed ID: 31606203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colorectal cancer-associated fibroblasts promote metastasis by up-regulating LRG1 through stromal IL-6/STAT3 signaling.
    Zhong B; Cheng B; Huang X; Xiao Q; Niu Z; Chen YF; Yu Q; Wang W; Wu XJ
    Cell Death Dis; 2021 Dec; 13(1):16. PubMed ID: 34930899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. α7 nicotinic acetylcholine receptor in tumor-associated macrophages inhibits colorectal cancer metastasis through the JAK2/STAT3 signaling pathway.
    Fei R; Zhang Y; Wang S; Xiang T; Chen W
    Oncol Rep; 2017 Nov; 38(5):2619-2628. PubMed ID: 28901507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oridonin represses epithelial-mesenchymal transition and angiogenesis of thyroid cancer via downregulating JAK2/STAT3 signaling.
    Liu W; Wang X; Wang L; Mei Y; Yun Y; Yao X; Chen Q; Zhou J; Kou B
    Int J Med Sci; 2022; 19(6):965-974. PubMed ID: 35813296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.